Published in Women's Health Weekly, December 25th, 2008
The drugs, called thiazolidinediones, help improve glycemic control and decrease insulin resistance in patients with diabetes.
The researchers looked at 10 randomized controlled trials of at least one year's duration involving 13 715 diabetes patients taking thiazolidinediones and those not taking the therapy. They found significantly reduced...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly